Skye Bioscience Inc (SKYE)

[Chefboy69]

exciting news...
On December 14, 2015, Nemus Bioscience, Inc. (the “Company”) entered into two license agreements (the “License Agreements”) with the University of Mississippi, School of Pharmacy, or UM, pursuant to which UM granted the Company exclusive, perpetual licenses of all intellectual property related to UM8930, a pro-drug formulation of Cannabidiol, that UM has previously developed, including the right to sublicense, and we have identified target indications for development and commercialization by us. The two licenses are for delivery of UM8930 through ocular and rectal delivery. The Company entered into an option for the rights to use UM8930 for delivery by other means not yet agreed upon which is renewable every six months.